Form D — CERO THERAPEUTICS HOLDINGS, INC.
0001470831-25-000015 · filed May 6, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $8,000,000
- Reported amount sold
- $5,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- CERO THERAPEUTICS HOLDINGS, INC.
- CIK
- 1870404
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 201 HASKINS WAY
SOUTH SAN FRANCISCO, California 94080 - Phone
- 650-407-2376
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Chris Ehrlich · Executive OfficerSouth San Francisco, California Find on LinkedIn ↗
-
Andrew Albert Kucharchuk · Executive OfficerSouth San Francisco, California Find on LinkedIn ↗
-
Kristen Pierce · Executive OfficerSouth San Francisco, California Find on LinkedIn ↗
-
Brian G. Atwood · DirectorSouth San Francisco, California Find on LinkedIn ↗
-
Michael Byrnes · DirectorSouth San Francisco, California Find on LinkedIn ↗
-
Kathleen LaPorte · DirectorSouth San Francisco, California Find on LinkedIn ↗
-
Shami Patel · DirectorSouth San Francisco, California Find on LinkedIn ↗
-
Lindsey Rolfe · DirectorSouth San Francisco, California Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗